Mental health disorders are a major public health problem, with an estimated one in four people in the United States experiencing a mental disorder in any given year.1 Treatment options for mental health disorders are limited, and often involve a combination of psychotherapy and medication. Recently, a new medication, lurasidone, has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. This article will discuss the potential benefits of lurasidone, as well as the potential risks associated with its use.
Lurasidone is an atypical antipsychotic medication that was approved by the US Food and Drug Administration in 2009. It is a serotonin-dopamine antagonist, meaning that it works by blocking the action of serotonin and dopamine, two neurotransmitters that are involved in the regulation of mood and behavior.2 Lurasidone is thought to be effective in treating a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder.
The primary benefit of lurasidone is its ability to reduce symptoms of mental health disorders. Studies have shown that lurasidone is effective in reducing the symptoms of bipolar disorder, schizophrenia, and major depressive disorder.3,4,5 In addition, lurasidone has been shown to be effective in reducing anxiety symptoms in people with bipolar disorder.6 In addition to reducing symptoms, lurasidone has also been shown to improve quality of life in people with mental health disorders. Studies have found that lurasidone can improve overall functioning and reduce the need for hospitalization in people with bipolar disorder and schizophrenia.7,8 Finally, lurasidone may be beneficial in reducing the risk of suicide in people with mental health disorders. Studies have found that lurasidone can reduce the risk of suicide attempts in people with bipolar disorder and schizophrenia.9,10
As with any medication, there are potential risks associated with lurasidone. The most common side effects of lurasidone include nausea, weight gain, fatigue, and dry mouth.11 Other potential side effects include increased blood sugar levels, increased risk of stroke, and increased risk of death in elderly patients with dementia.12 In addition, lurasidone can interact with other medications, including certain antidepressants and anticonvulsants.13 Therefore, it is important to discuss any potential medication interactions with your doctor before starting lurasidone.
Lurasidone is a new medication that has been developed to treat a variety of mental health disorders, including bipolar disorder, schizophrenia, and major depressive disorder. It is thought to be effective in reducing symptoms and improving quality of life in people with mental health disorders. However, there are potential risks associated with lurasidone, including side effects and interactions with other medications. Therefore, it is important to discuss the potential risks and benefits of lurasidone with your doctor before starting treatment.
1.
Health of Myeloma Patient's Marriage Tied to Recovery After Transplant
2.
Through Consolidation Durvalumab, Limited-Stage SCLC Receives a New Standard of Care.
3.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
4.
EBCC: European Breast Cancer Conference
5.
Charting the Course: From Young Adult Leukemia Patient to Oncologist.
1.
Frontiers in Cancer Therapeutics: U.S. Oncology Trials and Drug Discovery Trends
2.
A New Perspective on Spherocytosis: Uncovering Innovative Treatments
3.
Pathophysiology of Tumor Cell Extracellular Matrix Remodeling
4.
Innovative Advances in Oncology for Specialists
5.
Case Study: Diagnostic and Therapeutic Challenges in Aplastic Anemia Mimicking Hypoplastic Myelodysplastic Syndrome
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
2.
Importance of Cancer Screening and Early Detection
3.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation